Remote health monitoring for better care, lower costs

The economic and social burden of healthcare is weighing heavily on governments, healthcare providers and citizens, particularly as Europeans age. However e-health tools – such as mobile monitoring applications for patients and their care providers – are enabling care services to be redesigned to be more flexible and effective.

The mobility of chronically ill people, or those living with a condition that needs regular monitoring, is often limited. Their lives are planned around hospital visits, check ups and overnight stays. Many feel insecure when they are away from their healthcare providers and worry about risks to their health.

The HEALTHSERVICE 24 (HS24) project – with funding from the European Commission's eTEN programme – provides one solution to the challenges ahead. The project partners have developed an innovative mobile healthcare system that supports patients’ and health professionals' mobility, increases patients' quality of life and reduces healthcare costs.

"Our concept targets non-critical patients who use a lot of hospital resources, but because they are non-critical could be easily monitored from home," explains project coordinator Jennie Weingartner of Ericsson Germany in Düsseldorf. "HS24 gives them more freedom, while fulfilling one of Europe's e-health priorities to provide restructured, citizen-centred health systems."

High quality treatment and follow up anytime, anywhere
The system allows healthcare professionals to follow-up patients remotely, while the patients are free to continue their daily activities. It also enables these patients to monitor their own physical condition and obtain advice and information.

The number of chronically ill patients in Europe over the next decade is estimated to rise to more than 100 million. Weingartner says the economic potential of mobile health services is high. If just one out of 10 of these patients uses a mobile health service, it can result in substantial economic savings. "We expect mobile health services to play a fundamental role in transforming today's health model, allowing access to high quality treatment and follow-up, anytime from anywhere" she adds.

For example, in the UK the yearly costs for a person participating in a SEDS (Supervised Exercise, Diet and Stress management) programme is around 41,000 euros for conventional treatment. By contrast, the annual cost for mobile patient management is just 15,000 euros.

State-of-the-art networks and technology
The HS24 platform is based on advanced concepts and technologies such as Body Area Networks (BAN), 2.5/3G wireless broadband communications (GPRS/UMTS) and wearable medical devices. Users are equipped with sensors interconnected under a BAN, and managed by a PDA or mobile telephone. The collected data is transmitted continuously via a wireless UMTS or GPRS service to a medical centre or directly to medical professionals.

Content-management functions enable immediate analysis of individual body data and personalised patient feedback in real time using alarms and reminders. The system monitors vital signs such as ECG, EMG (electromyography), oxygen saturation, respiration, activity and temperature. "Patients can be remotely assessed, diagnosed and treated," says Weingartner. "In the case of rapidly deteriorating medical conditions, the data centre can send an SMS alarm or provide the patient with first-level medical support."

Benefits realised across the system
The benefits offered by such mobile systems can be realised across the healthcare profession. Patients benefit from better accessibility; while healthcare professionals can be more efficient and accurate in following up patient histories with easily available patient data. Families can reduce the time lost in visits to the hospital, which in turn reduces the number of occupied beds that require monitoring, making room for more critical patients.

Insurance companies and national governments also stand to benefit from reduced hospitalisation time for non-critical patients. Healthcare payers gain through reduced patient treatment costs, better resource management and significant health-economic improvements.

Patient trials a success
Project trials ran from September 2005 to July 2006, and involved patients with varying health conditions at three different sites. The goal was to test the system in real-life scenarios to assess the feasibility of integrating HS24 into the clinical process and testing market viability.

"Our trials showed that a mobile health monitoring system can easily co-exist with other forms of service delivery by supplementing them or replacing previous practices," says Weingartner. "Patients and medical practitioners are very enthusiastic about the system."

The monitoring of high risk pregnancies by one project partner, Medisch Spectrum Twente in the Netherlands, showed that the potential financial benefits can be very high, and that integrating mobile patient monitoring is feasible at low cost. At another site, the Hospital Clínic Provincial de Barcelona, Spain, HS24 was used to support remote assistance during home-visits to elderly and chronically ill patients suffering from Chronic Obstructive Pulmonary Disease (COPD).

A further partner, LITO Polyclinic in Cyprus, tested two groups of cardiac patients, those with an acute episode and those in a suspected acute episode. This trial revealed shortcomings in the 'wearability' of the system and some problems with connectivity, which were addressed in subsequent development.

"Professionals have concluded that the system could easily be applied to their current work practices," Weingartner adds. "We learned a very important lesson. The process of incorporating a mobile monitoring solution is more of a socio-technical nature. Technology alone is not enough."

Ericsson has developed a certified commercial product based on the HS24 concept. Today, Weingartner says Ericsson Mobile Health is ready for global rollout. "The HS24 research system will be further developed by the University of Twente and if new applications prove successful in pilots, it may be possible to integrate them into the commercial version," she concludes.

Contact:
Jennie Weingartner
Ericsson GmbH
Advice Business Consulting
Fritz-Vomfelde St. 26
D-40547 Düsseldorf
Germany
Tel: +49 211 534 2234
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...